Clinical trials expand potential, genetic research reveals insights, and patient stories highlight challenges.
The interplay between hepatocytes and T cells in autoimmune hepatitis, the potential of T cell biomarkers to predict relapse, and a case of chronic Epstein-Barr virus mimicking autoimmune hepatitis.
